Imatinib Intolerant
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tasigna in Glivec-resistant or Intolerant Patients in CML (NCT01206088) | Novartis Pharmaceuticals | 2009-02-01 |
Track Imatinib Intolerant automatically
Every clearance here is in the API, with alerts when new ones post.